NO20020043D0 - Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapi og forhindre en negativ medikament respons - Google Patents

Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapi og forhindre en negativ medikament respons

Info

Publication number
NO20020043D0
NO20020043D0 NO20020043A NO20020043A NO20020043D0 NO 20020043 D0 NO20020043 D0 NO 20020043D0 NO 20020043 A NO20020043 A NO 20020043A NO 20020043 A NO20020043 A NO 20020043A NO 20020043 D0 NO20020043 D0 NO 20020043D0
Authority
NO
Norway
Prior art keywords
anticoagulant
surrogate markers
patient
treating
prevent
Prior art date
Application number
NO20020043A
Other languages
English (en)
Norwegian (no)
Inventor
John Mcmichael
Original Assignee
Rxfiles Net Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rxfiles Net Corp filed Critical Rxfiles Net Corp
Publication of NO20020043D0 publication Critical patent/NO20020043D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
NO20020043A 1999-07-06 2002-01-04 Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapi og forhindre en negativ medikament respons NO20020043D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/348,592 US6267116B1 (en) 1999-07-06 1999-07-06 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
PCT/US2000/018576 WO2001002050A2 (fr) 1999-07-06 2000-07-06 Technique et systeme utilise pour traiter un patient avec un medicament, afin d'optimiser une therapie et d'empecher un effet secondaire de ce medicament

Publications (1)

Publication Number Publication Date
NO20020043D0 true NO20020043D0 (no) 2002-01-04

Family

ID=23368686

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20020043A NO20020043D0 (no) 1999-07-06 2002-01-04 Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapi og forhindre en negativ medikament respons
NO20020056A NO20020056D0 (no) 1999-07-06 2002-01-07 Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapien og forhindre en negativ medikamentrespons

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20020056A NO20020056D0 (no) 1999-07-06 2002-01-07 Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapien og forhindre en negativ medikamentrespons

Country Status (15)

Country Link
US (2) US6267116B1 (fr)
EP (1) EP1191894B1 (fr)
JP (1) JP2003503165A (fr)
KR (1) KR20020036790A (fr)
CN (1) CN1359276A (fr)
AT (1) ATE378015T1 (fr)
AU (1) AU5919800A (fr)
BR (1) BR0012241A (fr)
CA (1) CA2362429C (fr)
DE (1) DE60037116T2 (fr)
IL (1) IL147201A0 (fr)
MX (1) MXPA01013306A (fr)
NO (2) NO20020043D0 (fr)
TR (1) TR200103831T2 (fr)
WO (1) WO2001002050A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267116B1 (en) * 1999-07-06 2001-07-31 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6581606B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
US6575169B2 (en) * 1999-07-06 2003-06-10 The Rxfiles Corporation Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6581607B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response
AU2001284868A1 (en) * 2000-08-24 2002-03-22 The Rxfiles Corporation Method and system for anticoagulant dose revision
US6578582B2 (en) * 2001-08-24 2003-06-17 The Rxfiles Corporation Method and apparatus using IDS™ for multi-agent therapy
US6883521B2 (en) * 2001-08-24 2005-04-26 Dimensional Dosing Systems, Inc. Method and apparatus for dosing single and multi-agent therapy
WO2003026727A1 (fr) * 2001-09-28 2003-04-03 Lifevent Limited Procede et appareil d'administration de medicament
EP1692636A2 (fr) * 2003-12-12 2006-08-23 Petra Biotek, Inc. Procedes, progiciel, et systemes posologique a agent simple et a agents multiples et autres procedes connexes
DE602006019950D1 (de) * 2006-06-01 2011-03-17 Wila Bv Werkzeug mit automatischer Verriegelung
DE602006020699D1 (de) * 2006-06-01 2011-04-28 Wila Bv Auswechselbares Werkzeug/Manipulator Kombination
US20090216561A1 (en) * 2008-02-22 2009-08-27 Swedish Health Services Methods for management of anticoagulation therapy
US8112290B2 (en) 2008-05-16 2012-02-07 Adolor Corporation Methods for delivering a drug to a hospital patient for short-term use while minimizing long-term use of the drug
WO2010048020A1 (fr) * 2008-10-20 2010-04-29 Epitome Pharmaceuticals Limited Procédés et systèmes améliorant l'intervention pharmaceutique dans le contrôle de la coagulation
WO2011163506A2 (fr) 2010-06-23 2011-12-29 University Of Louisville Research Foundation, Inc. Procédés et kits de prédiction de la réponse à un agent érythropoïétique
WO2013049624A1 (fr) 2011-09-30 2013-04-04 University Of Louisville Research Foundation, Inc. Système et procédé de dosage personnalisé d'agents pharmacologiques
SG10201907682RA (en) 2012-10-05 2019-10-30 Mould Diane System and method for providing patient-specific dosing as a function of mathematical models
CA2988724C (fr) 2015-04-09 2023-10-10 Diane R. Mould Systemes et procedes de dosage specifique au patient
US20190043501A1 (en) * 2017-08-02 2019-02-07 Elements of Genius, Inc. Patient-centered assistive system for multi-therapy adherence intervention and care management
US12046341B2 (en) * 2021-10-05 2024-07-23 Bradford Rabin Methods and systems for electronically adjusting a dosing pattern of a patient undergoing a medical regimen
KR20240033436A (ko) 2022-09-05 2024-03-12 박세경 휴대용 머신러닝 기반의 약물 부작용 탐지 시스템
US12295943B2 (en) 2023-09-22 2025-05-13 Closed Loop Medicine Ltd Apixaban dosing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5365948A (en) * 1992-08-21 1994-11-22 J & W Mcmichael Software Inc. Method for use in treating a patient with FK 506 to prevent an adverse immune response
US5694950A (en) * 1992-08-21 1997-12-09 J & W Mcmichael Software, Inc. Method and system for use in treating a patient with immunosuppresants using whole blood level criteria to prevent an adverse immune response
US6581606B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
US6575169B2 (en) * 1999-07-06 2003-06-10 The Rxfiles Corporation Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6267116B1 (en) * 1999-07-06 2001-07-31 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6581607B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response

Also Published As

Publication number Publication date
ATE378015T1 (de) 2007-11-15
EP1191894A4 (fr) 2004-10-20
CN1359276A (zh) 2002-07-17
IL147201A0 (en) 2002-08-14
TR200103831T2 (tr) 2002-10-21
US6942614B1 (en) 2005-09-13
WO2001002050A2 (fr) 2001-01-11
CA2362429C (fr) 2005-07-05
AU5919800A (en) 2001-01-22
MXPA01013306A (es) 2002-07-02
JP2003503165A (ja) 2003-01-28
WO2001002050A3 (fr) 2002-01-10
US6267116B1 (en) 2001-07-31
BR0012241A (pt) 2002-03-26
DE60037116D1 (de) 2007-12-27
EP1191894A2 (fr) 2002-04-03
CA2362429A1 (fr) 2001-01-11
NO20020056L (no) 2002-01-07
EP1191894B1 (fr) 2007-11-14
DE60037116T2 (de) 2008-09-11
NO20020056D0 (no) 2002-01-07
KR20020036790A (ko) 2002-05-16

Similar Documents

Publication Publication Date Title
NO20020043D0 (no) Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapi og forhindre en negativ medikament respons
Watson et al. A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over‐anticoagulation with warfarin
NO996229L (no) Heparanase spesifikke molekylære prober og deres anvendelse i forskning og medisin
DE60040698D1 (de) Stimulationssystem
Johnson et al. Serum creatine phosphokinase in leptospirosis
ATE132757T1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
WO2003011215A3 (fr) Procede et systeme destines au traitement d'un patient avec une substance biologique permettant d'optimiser la therapie et d'empecher un effet indesirable
Rotstein et al. Effect of chloroform, xylene, and halothane on enamel and dentin microhardness of human teeth
WO2002082972A3 (fr) Technique et appareil destines au traitement d'un patient recevant un medicament quelconque permettant d'optimiser la therapie et de prevenir un effet secondaire de ce medicament
BR0001794A (pt) Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)
SE0102147D0 (sv) New methods
EP1162457A3 (fr) Système multiple de détermination de la coagulation et procédé pour son utilisation
EP1318474A3 (fr) Mécanismes de comptage
DK0568554T3 (da) Fremgangsmåde til påvisning af anti-RNA-antistoffer
Troulis et al. Dental extractions in patients on an oral anticoagulant: a survey of practices in North America
ES2095337T3 (es) Preparacion de pranoprofen de liberacion sostenida.
Lee The infection control of dental impressions
BRPI0416248A (pt) métodos para determinar se um paciente resistente a insulina é um respondedor a um tratamento terapêutico para resistência a insulina, e para predizer se um tratamento terapêutico para resistência a insulina será efetivo na melhoria de uma ou mais doenças associadas com resistência a insulina
Becker et al. Anticoagulation therapy and primary care internal medicine: A nurse practitioner model for combined clinical service
Vig Reducing laboratory aerosol contamination
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
Lawrence et al. Assessment of anticoagulation using activated clotting times in patients receiving intravenous enoxaparin during percutaneous coronary intervention
EA200700968A1 (ru) Фармацевтическая композиция для лечения сахарного диабета 2 типа
Gabra et al. Post-transfusion hepatitis
Shah et al. An unusual cause of renal impairment: A latex glove